• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症患者脑脊液中细胞间黏附分子-1(ICAM-1)和肿瘤坏死因子受体水平升高。

Increased levels of intercellular adhesion molecule-1 (ICAM-1) and tumor necrosis factor receptor in the cerebrospinal fluid of patients with multiple sclerosis.

作者信息

Tsukada N, Matsuda M, Miyagi K, Yanagisawa N

机构信息

Health Medical Center, Shinshu University, Matsumoto, Japan.

出版信息

Neurology. 1993 Dec;43(12):2679-82. doi: 10.1212/wnl.43.12.2679.

DOI:10.1212/wnl.43.12.2679
PMID:8255476
Abstract

We investigated the presence of soluble intercellular adhesion molecule-1 (sICAM-1) and soluble tumor necrosis factor receptor (sTNF-R) antigens in the CSF of patients with multiple sclerosis (MS) using a double-determinant ELISA. Patients with acute relapsing MS during an exacerbation (p < 0.001) and those with chronic progressive MS (p < 0.001) had significantly increased CSF levels of sICAM-1 compared with subjects with other neurologic diseases. CSF levels of sTNF-R were also significantly increased in patients with acute relapsing MS during an exacerbation (p < 0.001) and chronic progressive MS (p < 0.001) compared with subjects with other neurologic diseases. CSF levels of sICAM-1 and sTNF-R were positively correlated in patients with acute relapsing MS during an exacerbation (r = 0.81, p < 0.01) and chronic progressive MS (r = 0.86, p < 0.001). These results suggest that active immune reactions involving ICAM-1 and TNF-R production are present within the CNS and that both sICAM-1 and sTNF-R are important immunologic markers of the clinical activity of MS.

摘要

我们使用双检测酶联免疫吸附测定法(ELISA)研究了多发性硬化症(MS)患者脑脊液中可溶性细胞间黏附分子-1(sICAM-1)和可溶性肿瘤坏死因子受体(sTNF-R)抗原的存在情况。与患有其他神经系统疾病的受试者相比,处于病情加重期的急性复发型MS患者(p < 0.001)和慢性进展型MS患者(p < 0.001)脑脊液中的sICAM-1水平显著升高。与患有其他神经系统疾病的受试者相比,处于病情加重期的急性复发型MS患者(p < 0.001)和慢性进展型MS患者(p < 0.001)脑脊液中的sTNF-R水平也显著升高。在处于病情加重期的急性复发型MS患者(r = 0.81,p < 0.01)和慢性进展型MS患者(r = 0.86,p < 0.001)中,脑脊液中的sICAM-1水平和sTNF-R水平呈正相关。这些结果表明,中枢神经系统内存在涉及ICAM-1和TNF-R产生的活跃免疫反应,并且sICAM-1和sTNF-R都是MS临床活动的重要免疫标志物。

相似文献

1
Increased levels of intercellular adhesion molecule-1 (ICAM-1) and tumor necrosis factor receptor in the cerebrospinal fluid of patients with multiple sclerosis.多发性硬化症患者脑脊液中细胞间黏附分子-1(ICAM-1)和肿瘤坏死因子受体水平升高。
Neurology. 1993 Dec;43(12):2679-82. doi: 10.1212/wnl.43.12.2679.
2
Changes in serum levels of ICAM and TNF-R correlate with disease activity in multiple sclerosis.细胞间黏附分子(ICAM)和肿瘤坏死因子受体(TNF-R)的血清水平变化与多发性硬化症的疾病活动度相关。
Neurology. 1999 Sep 11;53(4):758-64. doi: 10.1212/wnl.53.4.758.
3
Soluble intercellular adhesion molecule-I (sICAM-I) in serum and cerebrospinal fluid of demyelinating diseases of the central and peripheral nervous system.中枢和周围神经系统脱髓鞘疾病患者血清和脑脊液中的可溶性细胞间黏附分子-1(sICAM-1)
Mult Scler. 1998 Feb;4(1):39-44. doi: 10.1177/135245859800400110.
4
Increased levels of soluble tumor necrosis factor receptor in patients with multiple sclerosis and HTLV-1-associated myelopathy.
J Neuroimmunol. 1994 Jun;52(1):33-40. doi: 10.1016/0165-5728(94)90159-7.
5
Soluble intercellular adhesion molecule-1 in serum and cerebrospinal fluid of clinically active relapsing-remitting multiple sclerosis: correlation with Gd-DTPA magnetic resonance imaging-enhancement and cerebrospinal fluid findings.临床活动期复发缓解型多发性硬化患者血清和脑脊液中可溶性细胞间黏附分子-1:与钆喷酸葡胺磁共振成像强化及脑脊液检查结果的相关性
Neurology. 1996 Dec;47(6):1535-41. doi: 10.1212/wnl.47.6.1535.
6
The soluble 60-kDa tumour necrosis factor receptor: no difference found between patients with relapsing-remitting multiple sclerosis and controls: increasing levels are associated with the recovery from Guillain-Barré syndrome.可溶性60 kDa肿瘤坏死因子受体:复发缓解型多发性硬化症患者与对照组之间未发现差异;水平升高与吉兰-巴雷综合征的恢复相关。
J Neurol. 1998 Dec;245(12):803-8. doi: 10.1007/s004150050290.
7
Possible role of transforming growth factor-beta in relapsing-remitting multiple sclerosis.转化生长因子-β在复发缓解型多发性硬化症中的可能作用。
Neurol Res. 1997 Dec;19(6):599-600. doi: 10.1080/01616412.1997.11740866.
8
Circadian rhythmicity of inflammatory serum parameters: a neglected issue in the search of biomarkers in multiple sclerosis.炎症性血清参数的昼夜节律:多发性硬化症生物标志物研究中的一个被忽视的问题。
J Neurol. 2013 Jan;260(1):221-7. doi: 10.1007/s00415-012-6622-3. Epub 2012 Aug 9.
9
Soluble intercellular adhesion molecule-1 (ICAM-1), endothelial leukocyte adhesion molecule-1 (ELAM-1), and tumor necrosis factor receptor (55 kDa TNF-R) in patients with acute Plasmodium falciparum malaria.急性恶性疟原虫疟疾患者体内的可溶性细胞间粘附分子-1(ICAM-1)、内皮白细胞粘附分子-1(ELAM-1)和肿瘤坏死因子受体(55 kDa TNF-R)
Clin Immunol Immunopathol. 1994 Jun;71(3):344-8. doi: 10.1006/clin.1994.1096.
10
Serum Levels of Biomarkers of Immune Activation and Associations With Neurological Impairment in Relapsing-Remitting Multiple Sclerosis Patients During Remission.复发缓解型多发性硬化症患者缓解期免疫激活生物标志物的血清水平及其与神经功能损害的关联
Biol Res Nurs. 2016 Jan;18(1):113-9. doi: 10.1177/1099800415583105. Epub 2015 Apr 24.

引用本文的文献

1
extract modulates arterial inflammatory response: a potential therapeutic use for atherosclerosis.提取物调节动脉炎症反应:对动脉粥样硬化的潜在治疗用途。
Nutr Res Pract. 2019 Aug;13(4):302-309. doi: 10.4162/nrp.2019.13.4.302. Epub 2019 Jul 5.
2
Theiler's virus infection: a model for multiple sclerosis.泰勒氏病毒感染:多发性硬化症的一个模型
Clin Microbiol Rev. 2004 Jan;17(1):174-207. doi: 10.1128/CMR.17.1.174-207.2004.
3
Tumour necrosis factor and anti-tumour necrosis factor approach to inflammatory demyelinating diseases of the central nervous system.
肿瘤坏死因子及抗肿瘤坏死因子疗法在中枢神经系统炎性脱髓鞘疾病中的应用
Ann Rheum Dis. 2000 Nov;59 Suppl 1(Suppl 1):i94-102. doi: 10.1136/ard.59.suppl_1.i94.
4
Blood levels of transforming growth factor-beta 1 (TGF-beta1) are elevated in both relapsing remitting and chronic progressive multiple sclerosis (MS) patients and are further augmented by treatment with interferon-beta 1b (IFN-beta1b).复发缓解型和慢性进展型多发性硬化症(MS)患者的血液中转化生长因子-β1(TGF-β1)水平均升高,且使用β-1b干扰素(IFN-β1b)治疗后会进一步升高。
Clin Exp Immunol. 1998 Jul;113(1):96-9. doi: 10.1046/j.1365-2249.1998.00604.x.
5
Low serum interleukin-10 levels in multiple sclerosis: further evidence for decreased systemic immunosuppression?多发性硬化症患者血清白细胞介素-10水平较低:全身免疫抑制降低的进一步证据?
J Neurol. 1996 Jan;243(1):13-7. doi: 10.1007/BF00878525.
6
Intercellular adhesion molecule-1.细胞间黏附分子-1
J Mol Med (Berl). 1996 Jan;74(1):13-33. doi: 10.1007/BF00202069.